2021 CMSC Annual Meeting

Tag: South San Francisco

Poster-Quality of Life and Outcomes

Understanding MS Symptoms and Impacts through Semi-Structured Interviews with Clinical Experts and People Living with MS

Background: Multiple sclerosis (MS) is a chronic progressive disease, affecting a broad range of important functions. In order to...

Read More

Poster-Quality of Life and Outcomes

Examining Fatigue in Progressive MS: Results from a Qualitative Study and Review of PRO Measures

Background: Although fatigue is one of the most common symptoms of multiple sclerosis (MS) and several patient-reported outcome (PRO)...

Read More

Poster-Neurophysiology; Neuropsychology and Neuropsychiatry

FlywheelMS: Stratification of Anxiety and Depression By MS Subtype As Captured in Digitized Health Records

Background: Anxiety and depression are among the most common comorbidities associated with multiple sclerosis (MS). Findings by MS subtype...

Read More

Poster-Methods of Care

Floodlight MS: Using the Jobs-to-be-Done Framework to Identify Unmet Needs in Multiple Sclerosis Care to Support Digital Medical Device Development

Background: Multiple sclerosis (MS) is a chronic disease, and people living with MS (PLwMS) often experience symptoms across numerous...

Read More

Poster-Methods of Care

Floodlight MS: Utilizing Rapid Prototyping and Human Factors Studies to Develop a Digital Medical Device for Patient-Centric MS Care

Background: In multiple sclerosis (MS), subtle disease progression starts early despite initial presentation. Early neurologic damage can...

Read More

Platform-Disease Management

Treating Minority Patients with Multiple Sclerosis: Development of the CHIMES Trial

Background: Black, African American (AA) and Hispanic/Latino (HA) patients with multiple sclerosis (MS) have greater disease severity and...

Read More

Platform-Neuroimaging

A Description of Real-World MRI Acquired in Patients with Multiple Sclerosis: Preliminary Insights from FlywheelMS

Background: Magnetic resonance imaging (MRI) in the context of routine care is an important tool that can inform clinical decisions in...

Read More

Platform-Disease Modifying Therapies

Design of the Phase II, Double-Blind, Placebo-Controlled Dose-Expansion Portion of a Two-Part, Phase I/II, Multicenter Trial in Progressive Multiple Sclerosis

Background: Infection with Epstein-Barr virus (EBV) is a necessary risk factor for the development of multiple sclerosis (MS) Abrahamyan S...

Read More